NCT02656628

Brief Summary

The purpose of this multi-center patient registry is to obtain first clinical results and to assess short and mid-term clinical outcome data of patients treated with DLS.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2015

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2014

Completed
10 months until next milestone

Study Start

First participant enrolled

May 1, 2015

Completed
9 months until next milestone

First Posted

Study publicly available on registry

January 15, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

January 21, 2016

Status Verified

January 1, 2016

Enrollment Period

1.5 years

First QC Date

July 4, 2014

Last Update Submit

January 20, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiographic callus formation and location of callus evaluation: Change over time

    The radiologic presence of callus at the four locations around the plate is overall evaluated by a central independent trauma fellow or radiologist: * Lateral (under the plate) * Medial (on the contra lateral cortex) * Anterior * Posterior "\*"for patients with insufficient signs of healing at the 6 months visit; otherwise preferable visit

    6 weeks, 12 weeks, 6 months, and (12)* months

Secondary Outcomes (8)

  • Fracture union

    6 weeks, 12 weeks, 6 months, and (12)* months

  • QuickDASH for patients with humerus fracture

    Time point: 6 and 12 weeks, 6 and (12)* months

  • WOMAC for patients with femur and tibia fractures

    Time point: 6 and 12 weeks, 6 and (12)* months

  • Full weight bearing or full use of the upper extremity

    6 and 12 weeks, 6 and (12)* months

  • Adverse Events related to the device or procedure

    intra-and postoperative; 6 and 12 weeks; 6 and (12)* months

  • +3 more secondary outcomes

Study Arms (1)

Fractures of humerus femur tibia

Dynamic Locking Screw 3.7mm and 5.0mm

Device: Dynamic Locking Screw 3.7mm and 5.0mm

Interventions

Treatment with DLS and locked plate constructs (small or large fragments)

Fractures of humerus femur tibia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who meet the in- and exclusion criteria and have signed an informed patient consent prior to surgery will be included.

You may qualify if:

  • Age: ≥18 years
  • Any of the following fracture types:
  • Proximal or diaphyseal humerus fracture
  • Diaphyseal or distal femur fracture
  • Diaphyseal, distal or proximal tibia fracture
  • Eligible for treatment with Synthes DLS and locked plate constructs (small or large fragments)
  • Patients able and willing to sign informed consent form
  • Patients able and willing to adhere to 12-months follow-up visits

You may not qualify if:

  • Polytrauma
  • Pregnant or nursing females
  • Patients already participating in an investigational trial
  • Patients who are not expected to survive the follow-up period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Princess Alexandra Hospital

Woolloongabba, Brisbane, Queensland, 4102, Australia

Location

MeSH Terms

Conditions

Femoral Fractures, Distal

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesLeg Injuries
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2014

First Posted

January 15, 2016

Study Start

May 1, 2015

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

January 21, 2016

Record last verified: 2016-01

Locations